Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 96 M96 M99 M101 M106 M90 M 396 M Research & development —————— — Operating income 168 M118 M174 M95 M107 M121 M 497 M Non-Operating Income, Total 10 M13 M9 M4 M7 M20 M 40 M Interest expense, net of interest capitalized 56 M57 M60 M59 M60 M61 M 240 M Non-Operating Income, excl. Interest Expenses -51 M-51 M-56 M-56 M-57 M-55 M -224 M Unusual income/expense 5 M7 M5 M1 M4 M14 M 24 M Pretax income 122 M74 M123 M40 M54 M80 M 297 M Equity in earnings —————— — Taxes 22 M12 M20 M-1 M9 M12 M 40 M Non-controlling/minority interest —————— — After tax other income/expense -30 M-17 M-20 M5 M-43 M-18 M -76 M Net income before discontinued operations 100 M62 M103 M41 M45 M68 M 257 M Discontinued operations —————— — Net income 100 M62 M103 M41 M45 M68 M 257 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 100 M62 M103 M41 M45 M68 M 257 M Basic earnings per share (Basic EPS) 0.920.560.940.360.390.59 2.28 Diluted earnings per share (Diluted EPS) 0.910.560.940.360.380.59 2.27 Average basic shares outstanding 109.42 M109.52 M110.17 M110.47 M115.64 M115.73 M — Diluted shares outstanding 109.68 M109.77 M110.42 M110.74 M116.14 M116.38 M — EBITDA 308 M257 M322 M246 M251 M264 M 1.08 B EBIT 168 M118 M174 M95 M107 M121 M 497 M Cost of revenue —6 M1 M——— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 140 M139 M148 M151 M144 M143 M 586 M